1348 related articles for article (PubMed ID: 26171115)
21. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
[TBL] [Abstract][Full Text] [Related]
22. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
23. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
24. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
Moneim AE
Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
[TBL] [Abstract][Full Text] [Related]
25. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
26. Autophagic degradation of tau in primary neurons and its enhancement by trehalose.
Krüger U; Wang Y; Kumar S; Mandelkow EM
Neurobiol Aging; 2012 Oct; 33(10):2291-305. PubMed ID: 22169203
[TBL] [Abstract][Full Text] [Related]
27. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease.
Zhang Y; Chen X; Zhao Y; Ponnusamy M; Liu Y
Rev Neurosci; 2017 Nov; 28(8):861-868. PubMed ID: 28704199
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G
Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838
[TBL] [Abstract][Full Text] [Related]
29. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
30. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models.
Ploia C; Antoniou X; Sclip A; Grande V; Cardinetti D; Colombo A; Canu N; Benussi L; Ghidoni R; Forloni G; Borsello T
J Alzheimers Dis; 2011; 26(2):315-29. PubMed ID: 21628793
[TBL] [Abstract][Full Text] [Related]
31. Tau Proteins and Tauopathies in Alzheimer's Disease.
Chong FP; Ng KY; Koh RY; Chye SM
Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
[TBL] [Abstract][Full Text] [Related]
32. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
[TBL] [Abstract][Full Text] [Related]
33. Can tau filaments be both physiologically beneficial and toxic?
King ME
Biochim Biophys Acta; 2005 Jan; 1739(2-3):260-7. PubMed ID: 15615644
[TBL] [Abstract][Full Text] [Related]
34. Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.
Gu JL; Liu F
Curr Med Sci; 2020 Dec; 40(6):1009-1021. PubMed ID: 33428128
[TBL] [Abstract][Full Text] [Related]
35. Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis.
Teixeira JP; de Castro AA; Soares FV; da Cunha EFF; Ramalho TC
Molecules; 2019 Dec; 24(23):. PubMed ID: 31816853
[TBL] [Abstract][Full Text] [Related]
36. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
39. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
40. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
